Explore
← New search
11 matching publication(s)
Multimodal data integration for biologically-relevant artificial intelligence to guide adjuvant chemotherapy in stage II colorectal cancer.
PMID 40472802 · EBioMedicine · 2025
L1
83/100
Integrating multi-omics data reveals the antitumor role and clinical benefits of gamma-delta T cells in triple-negative breast cancer.
PMID 40197136 · BMC Cancer · 2025
L1
59/100
Neoadjuvant sintilimab plus chemotherapy in EGFR-mutant NSCLC: Phase 2 trial interim results (NEOTIDE/CTONG2104).
PMID 38897205 · Cell Rep Med · 2024
L1
72/100
Decoding the tumor microenvironment and molecular mechanism: unraveling cervical cancer subpopulations and prognostic signatures through scRNA-Seq and bulk RNA-
PMID 38482016 · Front Immunol · 2024
L1
80/100
Machine Learning-Based Integrated Analysis of PANoptosis Patterns in Acute Myeloid Leukemia Reveals a Signature Predicting Survival and Immunotherapy.
PMID 38322112 · Int J Clin Pract · 2024
L1
71/100
A novel oxidative stress-related gene signature as an indicator of prognosis and immunotherapy responses in HNSCC.
PMID 38157249 · Aging (Albany NY) · 2023
L1
85/100
A urine extracellular vesicle lncRNA classifier for high-grade prostate cancer and increased risk of progression: A multi-center study.⚑
PMID 37852185 · Cell Rep Med · 2023
65/100
⚑
PD-1 blockade potentiates neoadjuvant chemotherapy in NSCLC via increasing CD127+ and KLRG1+ CD8 T cells.
PMID 37231145 · NPJ Precis Oncol · 2023
L1
40/100
Construction and Validation of an Immune Infiltration-Related Gene Signature for the Prediction of Prognosis and Therapeutic Response in Breast Cancer.⚑
PMID 33986754 · Front Immunol · 2021
L1
51/100
⚑
Prediction of prognostic signatures in triple-negative breast cancer based on the differential expression analysis via NanoString nCounter immune panel.
PMID 33138797 · BMC Cancer · 2020
L1
72/100
Gene-expression patterns in peripheral blood classify familial breast cancer susceptibility.
PMID 26538066 · BMC Med Genomics · 2015
L1
83/100